Grant: CIHR Fellowship
University of Toronto
$90,000.00
Role of TNF alpha in inflammation-induced impairments in glucagon-like peptide-1 release
EF 2012-13
Résumé
The rate of type 2 diabetes mellitus (T2DM) is increasing worldwide. T2DM is associated with obesity, which reduces the ability of the body to respond to insulin, leading to high blood sugar levels. Recently, obesity has also been shown to result in increased levels of inflammatory molecules, like tumour necrosis alpha (TNFa), in the blood - these factors are known to impair the normal actions of insulin. In contrast to TNFa, glucagon-like peptide 1(GLP-1) is a hormone that promotes both insulin secretion and insulin action, and is vital to maintaining normal blood glucose levels; however, the blood levels of GLP-1 are reduced in obesity. Therefore, we propose that TNFa has a direct role in this reduction in GLP-1 secretion. To address this, we will determine the effect of TNFa treatment on GLP-1 secretion from GLP-1-producing cells. Next, as we have already established that GLP-1-producing cells have receptors that respond to TNFa, the precise receptor and how it works inside the GLP-1-producing cell to reduce GLP-1 secretion will be investigated. Finally, how obesity affects GLP-1 secretion will be examined using mouse models that lack the TNFa receptor or that are treated with a TNFa inhibitor. TNFa is emerging as an important link between obesity and the development of diabetes. The results of these studies will enhance our understanding of how TNFa is able to alter the secretion of GLP-1, a hormone that is essential for normal blood glucose levels. Our findings will have direct relevance to the mechanisms underlying obesity-associated development of T2DM.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
269543
Name
Gagnon Jeffrey
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Role of TNF alpha in inflammation-induced impairments in glucagon-like peptide-1 release
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Diabetes; Glucagon-Like Peptide 1; Inflammation
Abstract
The rate of type 2 diabetes mellitus (T2DM) is increasing worldwide. T2DM is associated with obesity, which reduces the ability of the body to respond to insulin, leading to high blood sugar levels. Recently, obesity has also been shown to result in increased levels of inflammatory molecules, like tumour necrosis alpha (TNFa), in the blood - these factors are known to impair the normal actions of insulin. In contrast to TNFa, glucagon-like peptide 1(GLP-1) is a hormone that promotes both insulin secretion and insulin action, and is vital to maintaining normal blood glucose levels; however, the blood levels of GLP-1 are reduced in obesity. Therefore, we propose that TNFa has a direct role in this reduction in GLP-1 secretion. To address this, we will determine the effect of TNFa treatment on GLP-1 secretion from GLP-1-producing cells. Next, as we have already established that GLP-1-producing cells have receptors that respond to TNFa, the precise receptor and how it works inside the GLP-1-producing cell to reduce GLP-1 secretion will be investigated. Finally, how obesity affects GLP-1 secretion will be examined using mouse models that lack the TNFa receptor or that are treated with a TNFa inhibitor. TNFa is emerging as an important link between obesity and the development of diabetes. The results of these studies will enhance our understanding of how TNFa is able to alter the secretion of GLP-1, a hormone that is essential for normal blood glucose levels. Our findings will have direct relevance to the mechanisms underlying obesity-associated development of T2DM.
Competitiondate
201210
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Gagnon, Jeffrey
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~